Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OSTP Head Elevated To Cabinet; First Life Scientist In Role

Executive Summary

President Joe Biden turned to a familiar face to lead the White House Office of Science and Technology Policy (OSTP). A leader of the human genome project, Eric Lander served as co-chair to the president’s council of advisors on science and technology under President Barack Obama.

You may also be interested in...



Heads Of HHS, FDA Outline Biden's Budget Proposals To US Congress

US President Joe Biden’s proposed budget for fiscal 2022 allocates $133.7bn for HHS, a 23% increase for the department from fiscal 2021; the administration is also asking for $6.5bn for the FDA, an 8% increase from the agency’s current budget.

Stryker Seeks Exemption For Patient-Transport Devices

A petition submitted to the US FDA seeks to exempt class II powered patient-transport devices from premarket notification requirements.

FDA Warns Public Of Innova COVID-19 Test Risks

The US FDA has issued its highest-level warning on a COVID-19 test, citing faulty results that could lead to severe risks to public health.

Topics

UsernamePublicRestriction

Register

MT144046

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel